Ant Group Digital Technology and HSBC complete Agent "micro-payment" verification, enabling banks to access real-time authentication in the payment process
On October 9, Ant Digital Technologies and HSBC completed a technical validation of AI agent micropayment technology in Hong Kong. The test demonstrated a process in which an AI agent discovers and accesses digital services, initiates payment, and then undergoes real-time risk verification and settlement by HSBC.
Micropayments usually refer to small transactions of less than $2, but the specific payment amount for this test was not disclosed.
It is reported that the test used HSBC's tokenized deposit service, Ant Digital Technologies' Anvita Flow network, and the Jovay testnet, and remains at the technology exploration stage.
Bian Zhuoqun, President of Blockchain Business at Ant Digital Technologies, stated that this technical validation with HSBC showcased the potential uses of on-chain AI agents, and Ant Digital Technologies will continue to explore the application of autonomous agents in real-world business scenarios.
Lewis Sun, Global Head of Digital Currencies at HSBC, said that HSBC aims to enhance customer experience and reduce transaction friction through its tokenized deposit service and new application partnerships, while focusing on customer needs, appropriate controls, and responsible development.
There are already protocols and transaction activities for small-value payments between machines.
As of April this year, the x402 protocol had an adjusted cumulative transaction amount of about $15 million, involving approximately 109.6 million transactions. In addition, the Machine Payments Protocol launched by Stripe and Tempo completed settlements of about $25,000 a few weeks after going live.
These efforts reflect a new type of demand: software making payments to other software for a single API call or a small amount of computing power. The smaller and more frequent the transaction, the more automation is required for handling fees, reconciliation, and risk assessment.
The specific incremental advancement in this validation by Ant Digital Technologies and HSBC is allowing agents to autonomously complete service calls and payments on behalf of users or enterprises, and integrating the bank's real-time risk verification into the same process.
This differs from the aforementioned protocol for pure machine-to-machine transactions. According to HSBC, its tokenized deposit service can represent corporate deposits as on-chain digital certificates (at a 1:1 ratio to deposit accounts), supporting 24/7 near real-time transfers within the HSBC network. This service has already been launched in Hong Kong, Singapore, Luxembourg, the United Kingdom, the United States, and the United Arab Emirates.
This test integrated service invocation and bank settlement into the same technical process. Whether it will lead to practical applications will depend on how digital service providers are integrated, transaction costs, and the development of agent authorization rules.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Japanese Yen: Choppy trade inside defined range – UOB
BUZZ—U.S. Stock Market Update—SpaceX, Humana, Crescent Energy
Query string for tracking individual stock trends: STXBZ "Today's Outlook" newsletter: https://refini.tv/3LI4BU7 "Morning News Briefing": https://refini.tv/3dKUyB8 Reuters, October 9 – On Friday, U.S. stock indices are expected to open higher, boosted by falling oil prices as concerns over Middle East supply ease, although telecom stocks remain under pressure amid worries of increased industry-wide competition following SpaceX's spectrum acquisition. ** T-Mobile US Inc TMUS.O: In Discussion – European telecom stocks fell after SpaceX's spectrum deal nL6N45V0EH ** SpaceX SPCX.O: In Focus – Shares rose after reaching an agreement to acquire a nationwide low-band spectrum portfolio nL4N45V0KP ** Humana Inc HUM.N: In Focus – Shares rose on the back of an upgraded rating for its “Federal Medicare Advantage Plan” [nL4N45V0LU ** Definium Therapeutics Inc DFTX.O: Market Watch – Stock rose after JPMorgan rated its LSD-based therapies as “Overweight” nL4N45V0NH ** UnitedHealth Group Inc UNH.N: Market Update – TD Cowen lowered its price target ahead of UnitedHealth’s Q3 financials nL4N45V0OU ** Newmont Corporation NEM.N: ** Gold Fields Ltd GFI.N: ** Harmony Gold Mining Company HMY.N: ** AngloGold Ashanti AU.N: Market Update – Gold miner stocks rose modestly as gold prices moved up on weaker dollar nL4N45V0PG ** Delta Air Lines DAL.N: Market Flash – Shares dropped after sharply cutting its full-year profit guidance nL4N45V0RA ** Apple AAPL.O: In Focus – Shares fell on reports of iPhone production cuts nL4N45V0SB ** Crescent Energy CRGY.N: Market Update – Shares dropped after it raised $1 billion to acquire Devon Energy nL6N45V0J4 ** Medtronic MDT.N: ** Tandem Diabetes Care Inc TNDM.O: ** PROCEPT BioRobotics Corp PRCT.O: ** Insulet Corporation PODD.O: Market Update – Leerink says industry-wide growth concerns for med-tech may outweigh Q3 results nL4N45V0YE (For the convenience of non-English speakers, Reuters automates translation of its reports into several languages. Because automated translations may contain errors or fail to capture the intended context, Reuters does not guarantee the accuracy of these texts and provides them solely for reader convenience. Reuters assumes no liability for any damages or losses resulting from the use of automated translation features.)
BUZZ - Leerink says concerns over growth in the medical technology sector may overshadow third-quarter performance
October 9 – Leerink Partners stated that, ahead of the third-quarter earnings reports, it remains cautious on the medical technology sector and pointed out that the short-term market environment is “somewhat uncertain.” The firm noted increasing competition in some markets, including the cardiac devices and diabetes care sectors; uncertainty in surgical volumes amid rising costs; weak consumer confidence; and pressure on hospital budgets due to higher interest rates. “We believe that even if third-quarter results are positive, they may be overshadowed by ongoing market concerns about profitability and growth prospects for 2027 and beyond,” the broker said. The firm believes that positive factors for specific companies could help Medtronic (MDT.N) and Tandem Diabetes Care (TNDM.O) outperform the broader industry during these sector-wide headwinds. The broker said it remains most cautious on PROCEPT BioRobotics (PRCT.O) and Insulet (PODD.O), as a slowdown in adoption and intensifying competition may lead to lowered expectations for 2027. (For the convenience of non-English speakers, Reuters automatically translates its reports into several other languages. Since automated translation may contain errors or fail to capture the required context, Reuters does not guarantee the accuracy of automated translation texts, and they are provided merely for readers’ convenience. Reuters accepts no liability for any damage or loss resulting from the use of automated translation features.)
EUR/USD Price Forecast: Rallies fail above 1.1200 amid high Oil prices, debt woes
Crypto prices
More
